This clinical study was undertaken because the clinical literature dealing with the use of mannitol and inositol hexanitrate and to a large extent other nitrites and nitrates which have been used in the management of hypertension fails to consider the development of tolerance. It was found that tolerance to the vasodilator action of mannitol and inositol nitrate develops in from 8 to 14 days and is lost completely within 10 days after withdrawal of the drug. 
Q fUICKLY acting nitrites and nitrates have been used for decades for the relief of angina pectoris. By physiological methods it can be demonstrated that these drugs increase coronary blood flow provided the blood pressure is not reduced too much by a too large dose of the drug and the coronary vessels have not lost their capacity to dilate.
The more slowly acting nitrites and nitrates, especially the organic nitrates, have been and still are used extensively in the management of hypertension. They have been and are used more or less continuously to reduce the blood pressure on the assumption (A) that the hypertension is due to excessive peripheral vasoconstriction, some of which at least may be counteracted by the vasodilator effect of these compounds, and (B) that they are symptomatically beneficial.
This study was undertaken primarily (1) to determine the blood-pressure reducing effectiveness of a new compound, inositol hexanitrate and (2) of an old compound, mannitol hexanitrate, and (3) to ascertain if tolerance developes to the blood-pressure reducing effects of these two compounds. Because tolerance might develop, the study was not designed to examine critically the clinical effectiveness of the drugs or the best way to administer the drugs so as to avoid the development of tolerance, and in that way really test the value of From the Department of Clinical Science, Uni- versity of Illinois College of Medicine, Chicago, Ill. 353 these long-acting nitrates in the management of the hypertensive patient on the basis of the assumption that a reduction of blood pressure is symptomatically and prophylactically valuable. The clinician (L. B.) giving the medication, including a placebo, and supervising the patients did not know the entire purpose of the study and did not know the identity of the tablets. LITERATURE We have been unable to find in the literature a carefully designed study to test the assumption that a reduction of blood pressure in the hypertensive patient by the use of nitrites or nitrates is symptomatically and prophylactically valuable. This is primarily because no clinical investigator has considered adequately the development of tolerance to the blood-pressure reducing effects of the compound they used. This has occurred, even though some textbooks of pharmacology,' have since 1917 , pointed out that tolerance to the blood-pressure ieducing effects of nitrites and nitrates appears in a few days, is well-established in two to three weeks and that cessation for several days invariably re-establishes the original extent of susceptibility. 2 Tolerance to nitroglycerine wras apparently first observed in 1888.3 As early as 1898, LaWS4 described the development of tolerance among the employees of the manufacturers of nitroglycerine. It was referIed to again in the American literature in 1905.5 6 3MANAGEIAENT OF HYPERTENSION studied the blood-pressure reducing effects of several nitrites and nitrates, as regards latent period of action, extent and duration of the decrease in blood pressure, did not study tolerance (for a table giving  such data see references 1 and 9) . A number of clinicians prior to 1915 reported on the use of nitrites in the management of hypertension without mentioning the subject of tolerance.'0'" During World War I, attention was again directed to the tolerance developed by persons making nitroglycerin.'2' '3 (Some munition workers develop a tolerance readily and others do not; the latter usually discontinue such work.) But, prior to 1929 a carefully controlled study of the tolerance and cross tolerance to nitrites and nitrates had not been conducted. Then, Mleyers and Austin'4 found that rabbits developed within several days a definite tolerance to the blood-pressure reducing effects of sodium nitrite with a cross-tolerance to nitroglycerin. Crandall'1b found that dogs made tolerant to amyl nitrite are tolerant to the vascular effects of sodium nitrite. Crandall, Leake, Loevenhart, and M\uehl-bergerl5a using normal human subjects found that a tolerance to the headache-producing effect of the nitrites and nitrates developed faster than to the blood-pressure reducing effect. The ease of developing some tolerance to one headache dose ranked in order as follows: amyl nitrite (2 to 3 hours), methyl nitrate (24 hours), ethylene glycol dinitrate (32 hours), glycerol trinitrate (38 hours), and erythrol tetranitrate (60 hours). Cross tolerance was demonstrated. They failed to observe the development of tolerance to the vascular effects of sodium nitrite (0.22 Gm. two times a day) in four days in man and in six days in a dog (0.3 Gm., two or three times per day). In two subjects, however, tolerance to the vascular effects of sodium nitrite were abolished by rendering them tolerant to ethylene glycol dinitrate.
Since 1924, 19, 16-26 monographs or textbooks, and ten27-36 articles dealing with the treatment of hypertension reviewed by us do not mention the possibility of tolerance developing, and in that way annulling the potential benefit of the prolonged use of nitrites and nitrates. One author3 of a pedagogical article mentions the possibility of tolerance developing to all nitrites and nitrates as the subject is presented in textbooks of pharmacology." 2 The literature clearly establishes that adequate doses of the nitrites or nitrates usually employed therapeutically reduce blood pressure of normal subjects, the extent depending on the dose and the susceptibility of the subject.', 2, 7, 8, In order to avoid completely all prejudice, a "blind-placebo plan" of study was undertaken. At no time in the study did the clinical investigator know the identity of the three tablets used. He was instructed to give the three tablets to alternate patients as they became a member of the study group and to make certain observations with the objective that after several months the observations would show a difference or similarity in the action of the three tablets.
At each visit, the patient sat in a waiting room for approximately 30 minutes before entering the consultation room. The subjective complaints were discussed and recorded. The blood pressure was then determined to the nearest 5 mm. Hg mark in sitting, supine, and standing positions in the left arm and then on the right arm. In this report the pressure taken in the right arm in sitting position was arbitrarily chosen for comparisons. Thus, the value used was one which in all subjects followed sitting in the waiting room and the same changes of position during three blood pressure determinations.
The tablets were labeled X, Y, and Z. They contained respectively 30 and analysis of the data, the doses on all the patients were arbitrarily divided into two groups, namely, a "low dosage group" (two to six tablets four times daily) and a "high dosage group" (9 to 12 tablets four times daily).
In the "low dosage group", there were 130 complete series of determinations on each of the three tablets on Procedure: Six of our hypertensive patients whose blood pressure had been found repeatedly not to be lowered by relatively huge doses of mannitol and inositol hexanitrate were used in this experiment. Before using them all nitrate medication was discontinued for four weeks. Then, rotating at two week intervals a single dose of 12 tablets of mannitol (0.36 Gm.) and inositol (0.12 Gm.) hexanitrate and placebo were administered to each subject. The blood pressure was then determined at intervals up to four and one-half hours.
Results: The results, as averages, are graphed in figure 1. It will be noted that the placebo had no effect over a period of four and one half hours. The mannitol (0.36 Gm.) produced a marked fall in systolic (64 mm. Hg) and diastolic (32 mm. Hg) pressure which had not returned to the control pressure after four and one half hours. The inositol (0.12 Gm) produced a decided fall in systolic (44 mm. Hg) and diastolic (20 mm. Hg) pressure which had not returned to the control pressure after four and one half hours. produce tolerance to mannitol and inositol hexanitrate? Procedure: Fifteen hypertensive patients served as subjects. They were divided into two groups. One group consisted of eight patients whose systolic and diastolic blood pressures were greater than 150 and 100 mm. Hg, respectively. The second group consisted of seven patients whose systolic and diastolic pressures were under 150 and 100 mm. Hg, respectively.
Each patient was given a single dose of 12 tablets of each medication and the blood pressure was determined for a period of four hours. Twelve tablets four times per day were then administered, five of the 15 patients receiving tablet X, five tablet Y, and five tablet Z. The blood pressure of each of the 15 patients was taken on the second, third, fourth, sixth, and eighth days. The medication was then stopped for two weeks. Then the patients were given a new tablet. This was repeated until each of the 15 patients had received each tablet for a period of eight days, each period being broken by a twoweek period of no medication.
Results: Reference to figure 2 shows the averaged results on the first group of 8 patients. Figure 3 shows the results on the second group of seven patients.
In the first group ( fig. 3 ), it will be noted the tolerance to mannitol and inositol developed in eight days. In the second group, the results with inositol were variable, but tolerance to the mannitol was present but not complete at eight days.
The tolerance is apparently completely absent after discontinuing the drugs for 14 days. In a few patients who had neglected, we found, to take their medication for 10 days, tolerance had been completely lost.
Side Reactions: Side reactions, such as headaches, dizziness and palpitation, occurred when the dosage level was suddenly increased above the level of the tolerance which had been developed. In those cases where a small dose such as 60 mg. four times daily, was given and slowly increased to 0.4 Gm. of mannitol four times daily, there were no symptoms or the symptoms were minimal. A few patients were apparently unable in a period of one month to develop a complete tolerance to 0.4 Gm. of mannitol four times per day. Some Angina: In three patients who had frequent attacks of angina the frequency of the attacks was not affected, as might be anticipated in view of the development of tolerance. In these patients a cross-tolerance to nitroglycerin w-as observed in that the usual tablet of nitroglycerin sublingually was less effective in abolishing the angina.
No methemoglobinemia was detected spectroscopically while giving the nitrates at any dosage level.
Since most of the patients taking part in this study were asymptomatic, more subjective complaints were recorded when they received the nitrates than the placebo. It should be emphasized, however, that this investigation was not designed for such a purpose. If it had been patients with symptoms would have been selected and the drugs administered so as to have avoided the development of complete or almost complete tolerance.
DISCUSSION
Since tolerance to mannitol and inositol hexanitrate develop and since they decrease systolic and diastolic blood pressure in adequate doses, no clinical investigation that we have been able to find has used them properly in hypertensive patients to test the assumption that the reduction in such patients is symptomatically, if not prophylactically beneficial.
Our results show, we believe, that these organic nitrates when used should be used as is indicated in current textbooks of pharmacologyl 2. Furthermore, our results show that unless the dose is individualized, as first suggested by Mathew,7 these drugs are not being properly used. This applies both to the determination of the size and frequency of the initial dose which will lower blood pressure without producing undesirable side reactions and to the determination in each patient of the time required to develop tolerance to that dose and to lose the tolerance.
It would be important both from a clinical and pharmacological point of view to determine in each of a group of patients whether any symptomatic relief obtained during the period of the development of tolerance on the drug would carry over during a four-to five-day period while off the drug to lose the tolerance. This would be especially beneficial to that group of patients whose symptoms at first appear to be benefited.
We suspect that the continued rather extensive use by physicians of the organic nitrates 
